New drug
With quinine-based drugs, traditionally sought to treat malaria, failing to contain the disease anymore, scientists of the Central Institute of Medicinal and Aromatic Plants (cimap), based in Lucknow, have now developed a new drug in their war against the disease.
Certain strains of the malarial parasite have developed resistance to the quinine-based drugs. The new drug involves the conversion of arteminisinic acid into artemisinin, till now deemed unachievable in India; the drug, while available in China and Burma, was not available here.
Artemisinin is an anti-malarial compound -- active against the malarial parasite -- derived from the plant Artemisia annua, which is now being cultivated in the Kashmir valley. It has also been adapted to grow in the plains. A new liquid extraction technology developed by cimap led to the isolation of the artemisinin present in the flowers and leaves of the plant in low concentrations.
Related Content
- HIV drug resistance: brief report 2024
- Order of the National Green Tribunal regarding violation of environmental norms by Nectar Life Sciences Limited, village Haibatpur, tehsil Dera Bassi, District SAS Nagar (Mohali), Punjab, 05/01/2024
- World malaria report 2023
- Order of the High Court of Kerala regarding pricing of breast cancer medicines, 02/11/2023
- Approach paper on draft National Pharmaceuticals Policy 2023
- Inspection report filed by the Central Pollution Control Board regarding three pharmaceutical industries located in Choutuppal, Yadadri Bhuvanagiri district of Telangana, 20/10/2023